Publikationen in Zusammenarbeit mit Forschern von Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (15)

2024

  1. Appropriate Duration of Antimicrobial Treatment for Prosthetic Joint Infections: A Narrative Review

    Antibiotics, Vol. 13, Núm. 4

  2. Efficacy and safety of colistin plus beta-lactams for bone and joint infection caused by fluoroquinolone-resistant gram-negative bacilli: a prospective multicenter study

    Infection

  3. Executive summary: Guidelines for the diagnosis and treatment of septic arthritis in adults and children, developed by the GEIO (SEIMC), SEIP and SECOT

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 4, pp. 208-214

  4. Prosthetic Joint Infections Caused by Mycobacterium tuberculosis Complex—An ESGIAI–ESGMYC Multicenter, Retrospective Study and Literature Review

    Microorganisms, Vol. 12, Núm. 5

2023

  1. Antimicrobial resistance in Gram-negative bacilli in Spain: an experts’ view

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 1, pp. 65-81

  2. Cross neutralization of SARS-CoV-2 omicron subvariants after repeated doses of COVID-19 mRNA vaccines

    Journal of Medical Virology, Vol. 95, Núm. 1

  3. Early switch from intravenous to oral antibiotic treatment in bone and joint infections

    Clinical Microbiology and Infection, Vol. 29, Núm. 9, pp. 1133-1138

  4. Incidence, associated disease burden and healthcare utilization due to Staphylococcus aureus prosthetic joint infection in European hospitals: the COMBACTE-NET ARTHR-IS multi-centre study

    Journal of Hospital Infection, Vol. 142, pp. 9-17

  5. Randomized Clinical Trial of the Need for Antibiotic Treatment for Low-Risk Catheter-Related Bloodstream Infection Caused by Coagulase-Negative Staphylococci

    Antibiotics, Vol. 12, Núm. 5

2022

  1. Genomic Analysis of Ceftazidime/Avibactam-Resistant GES-Producing Sequence Type 235 Pseudomonas aeruginosa Isolates

    Antibiotics, Vol. 11, Núm. 7

  2. Microbiological and Molecular Features Associated with Persistent and Relapsing Staphylococcus aureus Prosthetic Joint Infection

    Antibiotics, Vol. 11, Núm. 8

  3. Preoperative and perioperative risk factors, and risk score development for prosthetic joint infection due to Staphylococcus aureus: a multinational matched case-control study

    Clinical Microbiology and Infection, Vol. 28, Núm. 10, pp. 1359-1366

  4. Rates and Predictors of Treatment Failure in Staphylococcus aureus Prosthetic Joint Infections According to Different Management Strategies: A Multinational Cohort Study—The ARTHR-IS Study Group

    Infectious Diseases and Therapy, Vol. 11, Núm. 6, pp. 2177-2203

  5. Strain-to-strain variability among Staphylococcus aureus causing prosthetic joint infection drives heterogeneity in response to levofloxacin and rifampicin

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 12, pp. 3265-3269

  6. The clinical meaning of biofilm formation ability: The importance of context

    Enfermedades Infecciosas y Microbiologia Clinica